Mckesson Corporation Wiki: A Leader in Healthcare Solutions

McKesson Corporation is a leader in healthcare solutions, providing a wide range of products and services to healthcare providers. The company has a long history of innovation, dating back to 1833 when it was founded by John McKesson and Charles Olcott.

McKesson operates in three main business segments: pharmaceutical distribution, medical-surgical distribution, and health information technology. This diversification allows the company to stay ahead of the curve in the rapidly changing healthcare landscape.

McKesson's pharmaceutical distribution segment is one of the largest in the country, serving over 40% of the U.S. retail pharmacy market. This segment provides a wide range of products, including brand-name and generic medications.

McKesson's commitment to innovation is evident in its development of cutting-edge healthcare technology solutions, such as its electronic health record system, Epic.

A unique perspective: Abbvie Company Profile

McKesson Corporation has a rich history that spans over 180 years. Founded in 1833 by John McKesson and Charles Olcott in New York City, the company initially focused on pharmaceutical import and wholesale business.

The company has undergone significant changes over the years. In 1853, McKesson & Robbins was formed following the addition of Daniel Robbins.

Here's a brief timeline of the company's major milestones:

In 1999, McKesson made a significant move by acquiring HBO & Company, a healthcare IT firm. This acquisition marked a major shift towards expanding the company's services beyond pharmaceuticals.

Here's an interesting read: Takeda Pharmaceutical Company

McKesson Corporation is a leader in healthcare technology and solutions. They support pharmaceutical manufacturers and payers in connecting patients with medication access, affordability, and adherence programs.

McKesson is an innovator in supply chain automation, pharmacy technology, digital solutions, and data analytics. They offer automated pharmacy distribution systems, which streamline the process of dispensing medications.

Their technology and innovation efforts also include cold chain logistics for vaccines and biologics. This ensures that temperature-sensitive medications are stored and transported at the right temperature.

McKesson is a pioneer in barcoding, pharmacy robotics, and radio frequency ID inventory tracking. These technologies are critical in modern healthcare logistics and help prevent errors.

See what others are reading: Cambridge Antibody Technology

Here are some of the specific technologies and solutions offered by McKesson:

McKesson Provider Technologies acquired Medcon, Ltd. in 2005, which provides web-based cardiac image and information management solutions for heart centers. This acquisition expanded McKesson's offerings in the healthcare technology space.

McKesson's customer base is impressive, with 50% of all health systems, 20% of all physician practices, and 25% of home care agencies using their solutions. They also serve 77% of health systems with more than 200 beds.

Check this out: ImClone Systems

McKesson Corporation has a significant presence in several regions around the world.

McKesson operates in Australia and New Zealand, providing telephone-based services to the healthcare industry.

The company's Asia-Pacific region has its head office in Sydney, with additional offices in Melbourne, Perth, Adelaide, Wellington, and Auckland.

McKesson employs close to 700 people across the Asia-Pacific region.

In Canada, McKesson has a large footprint, with various business units operating under the McKesson Canada name.

McKesson Canada acquired IDA, Guardian Pharmacy, and The Medicine Shoppe in 2012 for $920 million.

In Australia and New Zealand, McKesson operates as McKesson Asia-Pacific, providing telephone-based services to the healthcare industry.

McKesson's services include telephone triage, health information, advice, and referral, as well as mental health triage and case management, and chronic disease management.

Using specialised health call centre software, McKesson clinical staff take over one million calls per year from the community.

McKesson's Asia-Pacific head office is located in Sydney, with other offices in Melbourne, Perth, Adelaide, Wellington, and Auckland.

Across the Asia-Pacific region, McKesson employs close to 700 people.

Discover more: What Is a S Corporation

In Canada, McKesson Corporation has a significant presence. McKesson Canada is a wholly owned subsidiary of McKesson Corporation, established in 2002.

McKesson Canada operates various business units, including McKesson Pharmaceutical, McKesson Automation, McKesson Specialty, McKesson Health Solutions, and McKesson Information Solutions. These units provide a range of services to the Canadian healthcare system.

In 2012, McKesson agreed to purchase Canadian pharmacy chains IDA, Guardian Pharmacy, and The Medicine Shoppe from the Katz Group of Companies for $920 million. This deal expanded McKesson Canada's presence in the country.

McKesson Canada acquired Rexall from the Katz Group of Companies in 2016 for $3 billion. The deal was finalized in December 2016 after approval under the Investment Canada Act.

Broaden your view: Merck Group

McKesson is a pioneer in several areas of healthcare technology, including supply chain automation, pharmacy technology, and digital solutions. They've developed innovative systems like automated pharmacy distribution and cold chain logistics for vaccines and biologics.

McKesson's expertise in barcoding, pharmacy robotics, and radio frequency ID inventory tracking remains crucial in modern healthcare logistics. These technologies help streamline processes and improve accuracy.

As a founding member of the CommonWell Health Alliance, McKesson supports policies and technology standards that enable secure sharing of patient data. This improves care coordination across the healthcare ecosystem.

McKesson services over 50,000 pharmacy locations and supports more than 75% of U.S. hospitals in some aspect of supply, logistics, or support.

Here are some of the industries and organizations McKesson partners with:

McKesson Corporation is committed to corporate responsibility and ESG efforts. The company has implemented corporate sustainability goals focused on reducing carbon emissions.

McKesson aims to improve drug disposal and environmental safety. This is a crucial aspect of their ESG efforts, as the pharmaceutical industry has a significant environmental impact.

Promoting diversity, equity, and inclusion is another key aspect of McKesson's ESG efforts. By expanding access to essential medications in underserved communities, McKesson is making a positive impact on society.

McKesson's ESG efforts are focused on the following key areas:

By prioritizing ESG efforts, McKesson is taking proactive steps to mitigate business risks and contribute to a more sustainable future.

McKesson has faced significant fines and penalties for its role in the opioid epidemic. In 2008, the company paid $13 million in fines for failing to report large orders of hydrocodone.

The company's issues with opioid distribution continued, with a $150 million civil penalty in January 2017 for alleged violations of the Controlled Substances Act. McKesson was also required to suspend all sales of controlled substances from its distribution centers in Colorado, Florida, Ohio, and Michigan for multiple years.

In 2020, Oklahoma's Attorney General sued McKesson, alleging that the company's actions helped fuel the state's opioid crisis. The lawsuit claimed that McKesson provided enough opioids to every adult resident in Bryan County to have 144 hydrocodone tablets.

Discover more: Meyer Brothers Drug Company

In January 2022, McKesson agreed to pay $26 billion to settle with all but five of the states suing the company. This settlement was part of a larger agreement with other companies, including AmerisourceBergen and Johnson & Johnson, which could have faced up to $95 billion in penalties if the states had gone to court.

McKesson Corporation is a giant in the healthcare industry, with a commanding position in the healthcare supply chain and pharmaceutical distribution sectors.

As of 2023, McKesson was the nation's largest health care company and the ninth-largest company by total revenue on the Fortune 500, with earnings of US$3.56 billion on revenue of US$276.711 billion.

McKesson's financial performance has been marked by steady growth, particularly in its pharmaceutical distribution segment.

Here's a breakdown of McKesson's revenue and net income from 2005 to 2023:

McKesson has demonstrated resilience and adaptability, especially in response to global health challenges like the COVID-19 pandemic, which underscored the critical nature of its supply chain and healthcare services.

McKesson Corporation is a diversified healthcare services leader that has been making significant strides in various areas of healthcare. The company has formed joint ventures to transform oncology research, such as the joint venture between US Oncology Research and HCA Healthcare's Sarah Cannon Research Institute.

McKesson has also acquired several companies to enhance its services, including Rx Savings Solutions, Compile, and Medical Specialties Distributors. These acquisitions have helped the company to make prescription medications more affordable for patients and improve patient outcomes.

McKesson's efforts to expand its services include forming healthcare IT joint ventures, such as the one with Change Healthcare, and acquiring companies like CoverMyMeds and RxCrossroads. The company has also continued to invest in the Health Mart franchise and expanded its footprint by acquiring HBO & Company and General Medical Supply.

NDCHealth (Relay Health) has a rich history that spans over two decades. It was originally known as National Data Corporation, and later became NDC-Health Corp in 2001 after a spin-off of its payments division.

NDCHealth was acquired by McKesson in 2007, and began doing business as RelayHealth. This acquisition marked a significant milestone in the company's growth.

RelayHealth has since become the nation's leading pharmacy network, providing a range of services to healthcare providers and patients alike.

Here are some key facts about RelayHealth's acquisition by McKesson:

RelayHealth's acquisition has been a key part of McKesson's expansion into the healthcare services market.

McKesson Medical-Surgical (MMS) offers a large selection of national healthcare brands, along with McKesson's exclusive brand of medical products. They cater to various healthcare settings, including physician offices, surgery centers, home health agencies, DMEs, labs, and long-term-care facilities.

Their online medical supply ordering platform is designed to meet the needs of these healthcare providers.

McKesson Medical-Surgical has a strong presence in the market, serving as a trusted partner for medical-surgical supplies, equipment, and logistics services.

McKesson's acquisition of General Medical Supply, the nation's largest distributor of medical supplies and equipment, has further expanded their capabilities.

Their integrated delivery networks enable efficient and reliable delivery of medical supplies and equipment to healthcare providers.

McKesson Medical-Surgical is committed to providing high-quality medical products and services to support the delivery of quality patient care.

Their expertise spans a wide range of medical supplies and equipment, from basic medical essentials to specialized products for specific healthcare needs.

Here are some key areas where McKesson Medical-Surgical excels:

McKesson is committed to forging new strategic ventures to expand its healthcare expertise. This involves forming partnerships with other healthcare companies to deliver a wide range of financial, operational, and clinical benefits.

One notable example is the joint venture with Change Healthcare, which aims to provide comprehensive healthcare solutions. McKesson has also acquired CoverMyMeds to offer patients cost-effective solutions for medications.

In addition, McKesson has acquired RxCrossroads to provide biopharma manufacturers with customizable services and solutions. The company has also announced the acquisition of Medical Specialties Distributors to create new solutions that improve alternate-site delivery and distribution of patient care supplies.

Here are some key acquisitions that highlight McKesson's expansion of healthcare expertise:

These strategic moves demonstrate McKesson's dedication to expanding its healthcare expertise and delivering innovative solutions to patients and healthcare providers.

Recommended read: Sigma Healthcare

McKesson Corporation has a long history of building a best-in-class supply chain. The company was founded in 1833 by John McKesson and Charles Olcott, who formed the first-ever nationwide wholesale pharmaceutical drug distribution network.

McKesson's early success can be attributed to its ability to distribute essential goods, such as lozenges, during the 1918 flu pandemic.

Today, McKesson is the largest pharmaceutical distributor in North America, responsible for one-third of all prescription medications delivered in the U.S. It supplies a wide range of customers, including retail pharmacies, hospital systems, and long-term care facilities.

McKesson's supply chain capabilities have enabled it to become the largest U.S. distributor of wholesale pharmaceutical drugs, beverages, and chemicals.

Additional reading: List of Largest Pharmaceutical Mergers and Acquisitions

Building a best-in-class supply chain requires careful planning and execution. McKesson, a renowned pharmaceutical distributor, has been a pioneer in this field since its inception in 1833.

McKesson was founded by John McKesson and Charles Olcott to import and sell therapeutic drugs and herbal products. This marked the beginning of a nationwide wholesale pharmaceutical drug distribution network.

By 1918, McKesson had grown to become the largest U.S. distributor of wholesale pharmaceutical drugs, beverages, and chemicals. They even distributed lozenges in the hopes of preventing the spread of the deadly influenza pandemic.

Today, McKesson is the largest pharmaceutical distributor in North America, responsible for one-third of all prescription medications delivered in the U.S. They supply a wide range of customers, including retail pharmacies, hospital systems, and long-term care facilities.

McKesson's success can be attributed to its ability to adapt to changing market conditions and customer needs. Here are some key facts about McKesson's supply chain:

Seasonality Profile plays a crucial role in supply chain management, as it helps identify patterns in demand and pricing fluctuations. McKesson Corporation's Seasonality Profile shows that some months consistently close higher than others.

For instance, McKesson Corporation's data reveals that certain months, like January, tend to close higher than the previous month, indicating a surge in demand.

The percentages in McKesson Corporation's Seasonality Profile indicate how frequently each calendar month closes higher than the one before it.

McKesson has had a few notable ventures over the years. The company operated the Mosswood Wine Company from 1978 until 1987, when it was sold to focus on pharmaceuticals.

Gerald Asher, a well-known wine writer, founded and ran the Mosswood Wine Company during its time under McKesson's ownership.

Establishing new ventures is a key strategy for McKesson to expand its scope as a diversified healthcare services leader. This approach has allowed the company to transform oncology research and accelerate drug development.

One notable example is the joint venture between McKesson's US Oncology Research (USOR) and HCA Healthcare's Sarah Cannon Research Institute (SCRI). This partnership aims to increase availability and access to clinical trials in the community setting.

McKesson has also made strategic acquisitions to enhance its services. For instance, it acquired Rx Savings Solutions to help make prescription medications more affordable for patients.

In addition, McKesson acquired Compile, a healthcare data platform that accelerates its ability to commercialize data. This move is expected to help life sciences companies bring products to market in faster and better ways and improve patient outcomes.

McKesson has also launched InspiroGene by McKesson to address the complex challenges of bringing cell, gene, and advanced therapies to market.

Here are some key new ventures established by McKesson:

McKesson operated the Mosswood Wine Company from 1978 until 1987. The division was sold to maintain its focus on pharmaceuticals. It was founded and run by wine writer Gerald Asher.

McKesson's future looks bright, driven by advancements in healthcare technology and a growing demand for efficient healthcare supply chain solutions.

The company is well-positioned to capitalize on emerging trends in telemedicine, which will likely change the way healthcare is delivered.

McKesson's commitment to sustainable and ethical business practices sets it apart in a world that's increasingly focused on corporate responsibility.

Its initiatives to address healthcare disparities also position the company favorably in this regard.

McKesson is poised to take advantage of the growing demand for digital health records, which will make it easier for patients to access their medical information.

The company's focus on innovation will help it stay ahead of the curve in a rapidly changing healthcare landscape.